Key Highlights

  • 22.73% was the intraday gain in Helen of Troy (NASDAQ:HELE) to USD 36.26 after Empower Brands offered a non-binding proposal to acquire all shares for USD 37.00 in cash.
  • Array Technologies (NASDAQ:ARRY) rose 22.20% to USD 5.67 after agreeing to a stock-for-stock Merger with Shoals Technologies Group at an exchange ratio of 1.6931.
  • Supernus (NASDAQ:SUPN) quoted down 34.04% to USD 27.65 after its Indivior merger closed, a move that may reflect a share basis mismatch rather than an actual loss.
  • SHF Holdings (NASDAQ:SHFS) fell 18.51% alongside a non-binding Opifex term sheet and dilution concerns. Angi (NASDAQ:ANGI) climbed 29.96% following results and a reported cost reduction plan.

Helen of Troy (NASDAQ:HELE): Up 22.73% on a USD 37.00 Takeover Proposal

Helen of Troy (NASDAQ:HELE) was quoted at USD 36.26 on November 4, 2026, up 22.73%, with an implied prior close near USD 29.54 (calculated) and a gain of USD 6.72. Empower Brands sent a letter on November 4, 2026 laying out a non-binding offer to buy all shares for USD 37.00 in cash, which the bidder describes as a 28% premium to the October 30 close. Empower says it first reached out to management on July 27, 2026, offered USD 34.00 on August 19, saw that rejected on September 3, and lifted its bid to USD 37.00 on October 12. The bidder asserts there is no financing condition and that it could sign within about 45 days. These are the bidder's own statements, and the target had not publicly answered in the material reviewed. The stock sits about 2.0% below the proposal (simple arithmetic on two published numbers), which reflects deal risk at Helen of Troy (NASDAQ:HELE).

Array Technologies (NASDAQ:ARRY): Up 22.20% on a Shoals Merger

Array Technologies (NASDAQ:ARRY) was quoted at USD 5.67 on November 4, 2026, up 22.20%, with an implied prior close of USD 4.64 (calculated) and a gain of about USD 1.03 a share. A 7:01 a.m. ET company release, issued alongside third quarter results, announced a merger pact with Shoals Technologies Group. Each Shoals share converts into 1.6931 Array shares, and Shoals holders are expected to own about 65% of combined basic shares. Simple math puts the value near USD 9.60 per Shoals share at the intraday quote (calculated), and that figure moves with Array's price until closing. Completion is expected in the first quarter of 2027, subject to shareholder, regulatory and Nasdaq approvals. Management cites more than USD 100 million of annual adjusted EBITDA synergies within three years. Full-year 2026 adjusted EBITDA guidance fell to USD 190 million to USD 210 million, and Array Technologies (NASDAQ:ARRY) has a USD 317.5 million preferred Redemption commitment.

Supernus (NASDAQ:SUPN): Down 34.04% After Closing Its Indivior Merger

Supernus (NASDAQ:SUPN) was quoted at USD 27.65 on November 4, 2026, down 34.04%, implying a prior close near USD 41.92 and a decline of USD 14.27 (calculated). The Indivior merger closed on November 2, 2026, Supernus Pharmaceuticals was delisted, and the combined company, Supernus, Inc., began trading as SUPN on November 3, 2026. Each Supernus Pharmaceuticals share was swapped for 1.5401 Indivior shares, and Indivior holders received a one time special Cash Dividend of USD 1.0 billion, funded by a USD 650 million term Loan and existing cash. Simple arithmetic on two published figures gives USD 27.65 times 1.5401, about USD 42.58, which sits close to the calculated prior close. That suggests a possible basis mismatch rather than a real 34% loss, though this is our reading and not a company statement. No announcement dated November 2 through November 4, 2026 offers an operating explanation for Supernus (NASDAQ:SUPN).

SHF Holdings (NASDAQ:SHFS): Down 18.51% With a Non-Binding Opifex Term Sheet

SHF Holdings (NASDAQ:SHFS) slid 18.51%, or USD 0.0077, to USD 0.0339 intraday on November 4, 2026, implying a prior close near USD 0.0416 (calculated). No company announcement dated November 2 through November 4, 2026 was identified. On October 26, 2026 the company disclosed a non-binding term sheet to combine with Opifex Media, a creator economy business, valued at no less than USD 50 million, with Opifex holders set to own 85%. Closing requires diligence, a fairness opinion, Series B consent, stockholder approval and Nasdaq approval. Exclusivity lasts about 45 days from October 26, 2026. Separately, 23,914,988 shares were issued on Series B preferred conversions between July 1 and October 23, 2026, and the term sheet indicates a reverse split may be pursued. A non-binding deal can fall apart, and SHF Holdings (NASDAQ:SHFS) can move on very few trades.

Angi (NASDAQ:ANGI): Up 29.96% After Third-Quarter Results and Job Cuts

Angi (NASDAQ:ANGI) was quoted at USD 7.33 on November 4, 2026, up 29.96%, with an implied prior close near USD 5.64 (calculated) and a gain of roughly USD 1.69 a share. The company posted third-quarter 2026 results on November 3, 2026 and hosted a call on November 4 at 8:30 a.m. ET with new chief executive Michael Steib. Published coverage reported Revenue of USD 242 million, down 9%, and adjusted EBITDA of USD 42.2 million. Reports indicated the company expects about 300 job reductions, USD 50 million to USD 60 million of annual run-rate savings and USD 18 million to USD 30 million of restructuring charges. These numbers come from reports and should be checked against the 8-K and 10-Q. Cost cuts only lift margins if revenue stabilizes, and a 9% revenue decline shows Angi (NASDAQ:ANGI) is still losing lead volume.

Where Things Stand

Supernus (NASDAQ:SUPN) posted the largest quoted move at down 34.04%, though that may reflect a share basis mismatch after the Indivior merger, while Angi's 29.96% gain was the biggest rise. The shared theme is corporate restructuring: a takeover bid, a stock merger, a closed combination, a non-binding tie up and a cost program. Deals can collapse or change terms, and the next markers are board responses, Shareholder votes and filings.